Mark Moasser
7PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 16, 2023
A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies.Erica S Tsang, Rahul R Aggarwal, Mallika S Dhawan
|Feb 09, 2023
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF<sup>V600E</sup> colorectal tumors.Ana Ruiz-Saenz, Chloe E Atreya, Changjun Wang
|Dec 27, 2022
Molecular Pathways and Mechanisms of HER2 in Cancer Therapy.Kanwal P S Raghav, Mark M Moasser
|Jun 22, 2022
Inactivating Amplified HER2: Challenges, Dilemmas, and Future Directions.Mark M Moasser
|Dec 06, 2021
Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft models.Chi-Heng Wu, Linlin Wang, Chen-Yen Yang
|Jul 19, 2020
Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer.Manuela Terranova-Barberio, Nela Pawlowska, Mallika Dhawan
Pageof 2
Frequent Collaborators
2 joint publications
Jean-Philippe Coppé
2 joint publications
Ana Ruiz-Saenz
2 joint publications
René Bernards
2 joint publications
Pamela N Munster
1 joint publications
Christian Posch
1 joint publications
Kanwal P S Raghav
1 joint publications
Bo Pan
1 joint publications
Dana J Ramms
1 joint publications
Danislav S Spassov
1 joint publications
Yeonjoo C Hwang
